United Therapeutics Corporation (UTHR)

Add to Watchlists Create an Alert
66.35 -1.26  -1.86%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

United Therapeutics Corporation R&D Expense Quarterly:

50.43M for March 31, 2013
View Full Chart

United Therapeutics Corporation R&D Expense Quarterly Chart

    United Therapeutics Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 50.43M
    Dec. 31, 2012 37.48M
    Sept. 30, 2012 65.16M
    June 30, 2012 37.10M
    March 31, 2012 33.66M
    Dec. 31, 2011 48.64M
    Sept. 30, 2011 59.43M
    June 30, 2011 24.24M
    March 31, 2011 47.71M
    Dec. 31, 2010 61.92M
    Sept. 30, 2010 40.34M
    June 30, 2010 28.59M
    March 31, 2010 34.87M
    Dec. 31, 2009 41.03M
    Sept. 30, 2009 31.55M
    June 30, 2009 28.65M
    March 31, 2009 20.96M
    Dec. 31, 2008 179.75M
    Sept. 30, 2008 19.21M
    June 30, 2008 19.14M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    UTHR R&D Expense Quarterly Benchmarks

    Companies
    Pluristem Therapeutic 3.653M
    Celgene Corporation 452.40M
    Lannett Company 5.229M

    UTHR R&D Expense Quarterly Rankings

    Overall 97th percentile
    200 of 8009
    Sector 92nd percentile
    50 of 687 in Healthcare
    Industry 94th percentile
    14 of 248 in Biotechnology

    UTHR R&D Expense Quarterly Range, Past 5 Years

    Minimum 19.14M Jun 2008
    Maximum 179.75M Dec 2008
    Average 45.49M